TEV-56286

· Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TEV-56286, covering 2025-01-29 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy [Phase 2]